The Aesthetic Guide is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

FDA OKs new microcannula

Article-FDA OKs new microcannula

Miami Beach, Fla. — The Food and Drug Administration has approved Cosmofrance’s Dermasculpt, a flexible blunt-tip microcannula for non-bruising and virtually painless cosmetic injections, Medical News Today reports.

According to Cosmofrance, based here, Dermasculpt microcannulas are used to administer facial fillers in conjunction with the company’s Skin Sculpting Technique (SST). The mechanical stimulation of fibroblast generates new collagen triggered by the microcannula’s back-and-forth movement.

The company says the main benefits of the SST using Dermasculpt microcannulas are that there is virtually no bruising, considerably less pain, wider coverage due to single point of entry, and production of new collagen.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.